Cargando…
疫情防控常态下肺癌早筛的现状及进展
Lung cancer is the malignant tumor with the highest incidence in China. Early detection and identification of symptomatic lung cancer patients and timely screen out asymptomatic patients from high-risk groups require multiple cooperation. At present, although combined imaging, serology, genomics, pr...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849038/ https://www.ncbi.nlm.nih.gov/pubmed/33478188 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.47 |
_version_ | 1783645237697052672 |
---|---|
collection | PubMed |
description | Lung cancer is the malignant tumor with the highest incidence in China. Early detection and identification of symptomatic lung cancer patients and timely screen out asymptomatic patients from high-risk groups require multiple cooperation. At present, although combined imaging, serology, genomics, proteomics and other methods have been combined to screen for suspected lung cancer, there are still problems such as missed diagnosis and misdiagnosis. Meanwhile, the spread of the corona virus disease 2019 (COVID-19) epidemic has brought new challenges to early lung cancer screening. Under the normalization of epidemic prevention and control, the work of early lung cancer screening should be changed accordingly: improve the population's awareness of cancer prevention and control, strengthen the management of medical procedures, improve the efficiency of tumor detection, optimize detection technology, and utilize internet and big data platforms rationally. We should establish an ideal model, combining multiple screening methods, which is streamlined and efficient for early lung cancer screening under normal epidemic prevention and control. |
format | Online Article Text |
id | pubmed-7849038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-78490382021-02-04 疫情防控常态下肺癌早筛的现状及进展 Zhongguo Fei Ai Za Zhi 综述 Lung cancer is the malignant tumor with the highest incidence in China. Early detection and identification of symptomatic lung cancer patients and timely screen out asymptomatic patients from high-risk groups require multiple cooperation. At present, although combined imaging, serology, genomics, proteomics and other methods have been combined to screen for suspected lung cancer, there are still problems such as missed diagnosis and misdiagnosis. Meanwhile, the spread of the corona virus disease 2019 (COVID-19) epidemic has brought new challenges to early lung cancer screening. Under the normalization of epidemic prevention and control, the work of early lung cancer screening should be changed accordingly: improve the population's awareness of cancer prevention and control, strengthen the management of medical procedures, improve the efficiency of tumor detection, optimize detection technology, and utilize internet and big data platforms rationally. We should establish an ideal model, combining multiple screening methods, which is streamlined and efficient for early lung cancer screening under normal epidemic prevention and control. 中国肺癌杂志编辑部 2021-01-20 /pmc/articles/PMC7849038/ /pubmed/33478188 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.47 Text en 版权所有©《中国肺癌杂志》编辑部2021 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/. |
spellingShingle | 综述 疫情防控常态下肺癌早筛的现状及进展 |
title | 疫情防控常态下肺癌早筛的现状及进展 |
title_full | 疫情防控常态下肺癌早筛的现状及进展 |
title_fullStr | 疫情防控常态下肺癌早筛的现状及进展 |
title_full_unstemmed | 疫情防控常态下肺癌早筛的现状及进展 |
title_short | 疫情防控常态下肺癌早筛的现状及进展 |
title_sort | 疫情防控常态下肺癌早筛的现状及进展 |
topic | 综述 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849038/ https://www.ncbi.nlm.nih.gov/pubmed/33478188 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.47 |
work_keys_str_mv | AT yìqíngfángkòngchángtàixiàfèiáizǎoshāidexiànzhuàngjíjìnzhǎn AT yìqíngfángkòngchángtàixiàfèiáizǎoshāidexiànzhuàngjíjìnzhǎn AT yìqíngfángkòngchángtàixiàfèiáizǎoshāidexiànzhuàngjíjìnzhǎn AT yìqíngfángkòngchángtàixiàfèiáizǎoshāidexiànzhuàngjíjìnzhǎn |